Patient Preferences for Lung Cancer Interception Therapy.

ABSTRACT:

Importance

Interception therapy requires individuals to undergo treatment to prevent a future medical event, but little is known about preferences of individuals at high risk for lung cancer and whether they would be interested in this type of treatment.

Objective

To explore preferences of individuals at high risk for lung cancer for potential interception therapies to reduce this risk.

Design, setting, and participants

This survey study used a discrete-choice experiment and included hypothetical lung cancer interception treatments with 4 attributes: reduction in lung cancer risk over 3 years, injection site reaction severity, nonfatal serious infection, and death from serious infection. Respondents were assigned to a baseline lung cancer risk of 6%, 10%, or 16% over

SUBMITTER: Janssen EM 

PROVIDER: S-EPMC10638649 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature